Sangamo Therapeutics
SGMO
#8886
Rank
โ‚น12.93 B
Marketcap
โ‚น38.43
Share price
-6.56%
Change (1 day)
-81.07%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -โ‚น9.46 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น32.87 Million. In 2024 the company made an earning of -โ‚น8.8 Billion, an increase over its 2023 earnings that were of -โ‚น10.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น9.46 Billion7.41%
2024 -โ‚น8.8 Billion-17.27%
2023 -โ‚น10.64 Billion-40.88%
2022 -โ‚น18 Billion9.79%
2021 -โ‚น16.39 Billion41.52%
2020 -โ‚น11.58 Billion23.17%
2019 -โ‚น9.41 Billion36.33%
2018 -โ‚น6.9 Billion36.89%
2017 -โ‚น5.04 Billion-22.32%
2016 -โ‚น6.49 Billion54.86%
2015 -โ‚น4.19 Billion75.62%
2014 -โ‚น2.39 Billion0.13%
2013 -โ‚น2.39 Billion
2011 -โ‚น3.21 Billion43.66%
2010 -โ‚น2.23 Billion28.52%
2009 -โ‚น1.74 Billion-23.55%
2008 -โ‚น2.27 Billion2.45%
2007 -โ‚น2.22 Billion19.5%
2006 -โ‚น1.86 Billion50.78%
2005 -โ‚น1.23 Billion75%
2004 -โ‚น0.71 Billion-33.25%
2003 -โ‚น1.06 Billion-62.27%
2002 -โ‚น2.79 Billion102.82%
2001 -โ‚น1.38 Billion23.21%
2000 -โ‚น1.12 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚น883.60 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.64 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น736.84 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น170.17 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น66.5 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.895 T-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น60.71 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.063 T-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA